Elevance Health, Inc. (NYSE:ELV) is a top pick for cheap healthcare stocks in 2026, with a ‘Buy’ rating and a target price of $394, offering a 19.12% upside potential. TD Cowen named it the “Best Idea for 2026,” with a price target of $400.00 and a favorable 2026 EPS estimate of $27.25.

Mizuho recently lowered Elevance Health, Inc.’s price target to $400 from $420, maintaining an ‘Outperform’ rating due to challenges in Carelon. The Indiana-based company operates in four segments and aims to simplify the healthcare system.

While ELV shows promise, other AI stocks may offer better returns with less risk. For a potentially undervalued AI stock with growth potential, check out our free report on the best short-term AI stock. Explore more insights on Dow stocks and unstoppable stocks for investment opportunities.

Read more at Yahoo Finance: Wall Street Outlook For Elevance Health, Inc. (ELV) Supported By Prior TD Cowen Upgrade